[Clinical experience with aminodeoxykanamycin (Kanendomycin 'Meiji') in the treatment of bacillary dysentery].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003510:Cyclohexanes / Q000009:adverse effects / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004405:Dysentery, Bacillary / Q000188:drug therapy*; D005260:Female; D006027:Glycosides / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008034:Lincomycin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012764:Shigella sonnei / Q000187:drug effects
D000900:Anti-Bacterial Agents; D003510:Cyclohexanes; D006027:Glycosides; D008034:Lincomycin